Literature DB >> 33710511

Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort study.

Mamoru Morikawa1,2, Shigetaka Matsunaga3,4, Shintaro Makino5,4, Yoshiharu Takeda6,4, Hironobu Hyoudo7,4, Masafumi Nii8,4, Mariko Serizawa9,4, Atsuo Itakura10,4, Tomoko Adachi6,4, Takao Kobayashi9,4.   

Abstract

Japanese obstetrical hemorrhage recommendations state that not only pregnant women with an obstetrical disseminated intravascular coagulation (DIC) score ≥ 8 points but also those with fibrinogen levels ≤ 1.5 g/L have a high risk of maternal death and warrant blood transfusion. Our aim was to demonstrate the potential of fibrinogen levels ≤ 1.5 g/L as predictors of a Japanese obstetrical DIC score of ≥ 8. We included 595 participants with blood loss ≥ 1000 mL during vaginal delivery or ≥ 2000 mL during cesarean delivery. The frequency and volume of red blood cell (RBC), fresh-frozen plasma, platelet concentrate (PC), and fibrinogen administration in women with a DIC score of ≥ 8 and fibrinogen levels of ≤ 1.5 g/L were significantly higher than controls (P < 0.0001). Multivariate analysis demonstrated that a score of ≥ 3 was associated with RBC or fibrinogen administration and a score of ≥ 5 was associated with PC transfusion. Fibrinogen levels ≤ 1.89 g/L and ≤ 2.44 g/L were associated with PC transfusion and fibrinogen administration, respectively. Fibrinogen levels ≤ 1.5 g/L may have similar potential to a DIC score of ≥ 8 points for detecting obstetrical DIC in Japan.

Entities:  

Keywords:  Coagulopathy; Diagnosis; Disseminated intravascular coagulation; Fibrinogen; Pregnancy

Mesh:

Substances:

Year:  2021        PMID: 33710511     DOI: 10.1007/s12185-021-03119-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

Review 1.  Diagnosis and management of acute obstetrical DIC.

Authors:  T Kobayashi; T Terao; M Maki; T Ikenoue
Journal:  Semin Thromb Hemost       Date:  2001       Impact factor: 4.180

2.  Japanese Clinical Practice Guide for Critical Obstetrical Hemorrhage (2017 revision).

Authors:  Satoru Takeda; Shintaro Makino; Jun Takeda; Naohiro Kanayama; Takahiko Kubo; Akihito Nakai; Shunji Suzuki; Hiroyuki Seki; Katsuo Terui; Shoichi Inaba; Shigeki Miyata
Journal:  J Obstet Gynaecol Res       Date:  2017-07-24       Impact factor: 1.730

3.  Obstetrical disseminated intravascular coagulation score.

Authors:  Takao Kobayashi
Journal:  J Obstet Gynaecol Res       Date:  2014-06       Impact factor: 1.730

4.  Guidelines for obstetrical practice in Japan: Japan Society of Obstetrics and Gynecology (JSOG) and Japan Association of Obstetricians and Gynecologists (JAOG) 2014 edition.

Authors:  Hisanori Minakami; Tsugio Maeda; Tomoyuki Fujii; Hiromi Hamada; Yoshinori Iitsuka; Atsuo Itakura; Hiroaki Itoh; Mitsutoshi Iwashita; Takeshi Kanagawa; Makoto Kanai; Yoshio Kasuga; Masakiyo Kawabata; Kosuke Kobayashi; Tomomi Kotani; Yoshiki Kudo; Yasuo Makino; Shigeki Matsubara; Hideo Matsuda; Kiyonori Miura; Takeshi Murakoshi; Jun Murotsuki; Akihide Ohkuchi; Yasumasa Ohno; Yoko Ohshiba; Shoji Satoh; Akihiko Sekizawa; Mayumi Sugiura; Shunji Suzuki; Tsuneo Takahashi; Yuki Tsukahara; Nobuya Unno; Hiroyuki Yoshikawa
Journal:  J Obstet Gynaecol Res       Date:  2014-06       Impact factor: 1.730

5.  A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC.

Authors:  T Terao; M Maki; T Ikenoue
Journal:  Asia Oceania J Obstet Gynaecol       Date:  1987-03

6.  Clinical evaluation of antithrombin III concentrate (BI 6.013) for disseminated intravascular coagulation in obstetrics. Well-controlled multicenter trial.

Authors:  M Maki; T Terao; T Ikenoue; T Takemura; K Sekiba; K Shirakawa; H Soma
Journal:  Gynecol Obstet Invest       Date:  1987       Impact factor: 2.031

7.  Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation.

Authors:  Takao Kobayashi; Masahiro Kajiki; Katsuhito Nihashi; Goichi Honda
Journal:  Thromb Res       Date:  2017-09-18       Impact factor: 3.944

8.  Pre-delivery fibrinogen predicts adverse maternal or neonatal outcomes in patients with placental abruption.

Authors:  Liangcheng Wang; Shigetaka Matsunaga; Yukiko Mikami; Yasushi Takai; Katsuo Terui; Hiroyuki Seki
Journal:  J Obstet Gynaecol Res       Date:  2016-04-14       Impact factor: 1.730

9.  The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study.

Authors:  Masato Yoshihara; Kaname Uno; Sho Tano; Michinori Mayama; Mayu Ukai; Shinya Kondo; Tetsuya Kokabu; Yasuyuki Kishigami; Hidenori Oguchi
Journal:  Crit Care       Date:  2015-10-20       Impact factor: 9.097

10.  Decline in maternal death due to obstetric haemorrhage between 2010 and 2017 in Japan.

Authors:  Junichi Hasegawa; Shinji Katsuragi; Hiroaki Tanaka; Akiko Kurasaki; Masamitsu Nakamura; Takeshi Murakoshi; Masahiko Nakata; Naohiro Kanayama; Akihiko Sekizawa; Ishiwata Isamu; Katsuyuki Kinoshita; Tomoaki Ikeda
Journal:  Sci Rep       Date:  2019-07-30       Impact factor: 4.379

View more
  2 in total

1.  Reference intervals of red blood cell parameters and platelet count for healthy adults in Japan.

Authors:  Akiyoshi Takami; Shinichiro Watanabe; Yoshikazu Yamamoto; Hiroshi Kondo; Yukiharu Bamba; Masahiko Ohata; Seiji Mishima; Hiroshi Kubota; Akihiko Nishiura; Reiko Miura; Miyuki Iwagami; Katsumi Higashi; Yutaka Yatomi; Kaoru Tohyama
Journal:  Int J Hematol       Date:  2021-06-02       Impact factor: 2.490

2.  Unilateral uterine artery embolization and Bakri tamponade balloon insertion in the treatment of acute puerperal uterine inversion: a case report.

Authors:  Wataru Isono; Akira Tsuchiya; Asuka Okamura; Michiko Honda; Ako Saito; Hiroko Tsuchiya; Reiko Matsuyama; Akihisa Fujimoto; Osamu Nishii
Journal:  J Med Case Rep       Date:  2022-05-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.